Bristol-Myers Squibb Company

NYSE: BMY
$56.30
+$0.35 (+0.6%)
Real Time Data Delayed 15 Min.

BMY Articles

The Johnson brothers started Johnson & Johnson in 1886 JHVEPhoto / iStock Editorial via Getty Images The iconic healthcare giant was started by Robert, James, and Edward Johnson in 1886 after...
The last trading day before the Christmas holiday has stocks headed for a mixed opening following a good, not great, inflation report.
While many investment professionals suggest short Treasury paper and money markets, healthcare is the place in 2024 for long-term investors looking for growth and income. Demand is growing as the...
2023 has been a much better year than 2022, as all major indices are higher. The tech-heavy Nasdaq is up a whopping 32.5%, while the venerable S&P 500 is up 15.36% and the Dow Jones Industrial...
Private equity firms and institutions have been buying up top health care stocks like these seven for their strong total return potential and a degree of safety in what soon could be some very rough...
Thursday's top analyst upgrades and downgrades included Amazon.com, Bristol-Myers Squibb, Coherent, Deere, GoDaddy, Pinterest, Rexford Industrial Realty, Salesforce, Uber Technologies, Vale,...
For some investors, buying long-dated call options on blue chip stocks that have lagged the market makes sense now. These five outstanding Goldman Sachs stock picks fit the bill and look very...
These four companies, including one Dow Jones industrial, are set to report quarterly earnings early Thursday.
Here is a look at what to expect when these three companies report quarterly results before markets open on Wednesday.
Monday's additional top analyst upgrades and downgrades were on Bristol Myers Squibb, Ford, Fortinet, General Motors, Kraft Heinz, Kroger, Merck, Procter & Gamble, Toast and more.
Tuesday's top analyst upgrades and downgrades included Bristol-Myers Squibb, Costco Wholesale, Dollar General, Exxon Mobil, FedEx, Horizon Therapeutics, Hyatt Hotels, Lucid, Medtronic, Micron...
Wednesday's additional top analyst upgrades and downgrades were on Block, Bristol-Myers Squibb, Clorox, CSX, Kimberly-Clark, Merck, Match, Target and more.
The bear market rally that started in June is over and it is clearly a time to move to safer dividend stocks. These eight outstanding health care stocks make sense for worried investors now as they...
Monday's top analyst upgrades and downgrades included Bristol-Myers Squibb, Cheniere Energy, Chewy, Costco Wholesale, CrowdStrike, Exact Sciences, Lululemon Athletica, New York Community Bancorp,...